/ZEN.V
ZEN.V Stock - Zentek Ltd.
Healthcare|Medical - Instruments & SuppliesTSXV
$1.00-4.76%
$0.05 (-4.76%) • Dec 22
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.5
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ZEN.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.99 – $1.01
TARGET (TP)$1.15
STOP LOSS$0.92
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.49
52W High$2.50
52W Low$0.85
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $872,495 | $29,816 | $72,855 | $339,666 | $2,355 |
| Gross Profit | $192,485 | $-385,059 | $-780,481 | $-275,044 | $-124,444 |
| Gross Margin | 22.1% | -1291.5% | -1071.3% | -81.0% | -5284.2% |
| Operating Income | $-9,600,632 | $-11,978,518 | $-14,149,536 | $-12,562,665 | $-3,984,907 |
| Net Income | $-10,039,658 | $-11,703,990 | $-14,414,266 | $-38,694,048 | $-3,868,650 |
| Net Margin | -1150.7% | -39254.1% | -19784.9% | -11391.8% | -164273.9% |
| EPS | $-0.10 | $-0.12 | $-0.14 | $-0.42 | $-0.05 |
Company Overview
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ZEN.VBeat Rate
13%
Last 8 quarters
Avg Surprise
-30.6%
EPS vs Estimate
Beats / Misses
1/6
1 met exactly
Latest EPS
$-0.02
Q4 2025
EPS Surprise History
Q4 23
-12.7%
$-0.03vs$-0.03
Q1 24
-33.1%
$-0.03vs$-0.02
Q2 24
-143.6%
$-0.02vs$-0.01
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | — | $-0.02 | — | — |
Q2 2025 | Jun 26, 2025 | — | $-0.01 | — | — |
Q1 2025 | Feb 12, 2025 | — | $-0.03 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.03 | — | — |
Q3 2024 | Aug 12, 2024 | — | $-0.03 | — | — |
Q2 2024 | Jun 26, 2024 | $-0.01 | $-0.02 | -143.6% | ✗ MISS |
Q1 2024 | Feb 12, 2024 | $-0.02 | $-0.03 | -33.1% | ✗ MISS |
Q4 2023 | Nov 13, 2023 | $-0.03 | $-0.03 | -12.7% | ✗ MISS |
Q3 2023 | Aug 11, 2023 | $-0.03 | $-0.03 | -5.6% | ✗ MISS |
Q2 2023 | Jun 29, 2023 | $-0.03 | $-0.03 | +8.5% | ✓ BEAT |
Q1 2023 | Feb 10, 2023 | $-0.03 | $-0.03 | 0.0% | = MET |
Q4 2022 | Nov 14, 2022 | $-0.03 | $-0.04 | -33.3% | ✗ MISS |
Q3 2022 | Aug 5, 2022 | $-0.04 | $-0.05 | -25.0% | ✗ MISS |
Q2 2022 | Jun 29, 2022 | — | $-0.32 | — | — |
Q1 2022 | Feb 28, 2022 | — | $-0.02 | — | — |
Q4 2021 | Nov 29, 2021 | — | $-0.03 | — | — |
Q3 2021 | Aug 27, 2021 | — | $-0.02 | — | — |
Q3 2021 | Jul 28, 2021 | — | $-0.01 | — | — |
Q1 2021 | Feb 26, 2021 | — | $-0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ZEN.V
What is ZEN.V's current stock price?
Zentek Ltd. (ZEN.V) is currently trading at $1.00 per share. The stock has moved -4.76% today.
What is the analyst price target for ZEN.V?
No analyst price targets are currently available for this stock.
What sector is Zentek Ltd. in?
Zentek Ltd. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the TSXV exchange.
What is ZEN.V's market cap?
Zentek Ltd. has a market capitalization of $0.10 billion, making it a small-cap company.
Does ZEN.V pay dividends?
No, Zentek Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBNXT.CN
BioNxt Solutions Inc.
$0.65
Mkt Cap: $0.1B
CRDL.TO
Cardiol Therapeutics Inc.
$1.40
Mkt Cap: $0.1B
GRIN.CN
Grown Rogue International Inc.
$0.57
Mkt Cap: $0.1B
MDNA.TO
Medicenna Therapeutics Corp.
$0.99
Mkt Cap: $0.1B
MSCL.TO
Satellos Bioscience Inc.
$0.66
Mkt Cap: $0.1B
OTC.V
Ocumetics Technology Corp.
$0.64
Mkt Cap: $0.0B
PLTH.CN
Planet 13 Holdings Inc.
$0.30
Mkt Cap: $0.1B
QIPT.TO
Quipt Home Medical Corp.
$4.84
Mkt Cap: $0.2B
RX.V
BioSyent Inc.
$12.30
Mkt Cap: $0.1B
SONA.CN
Sona Nanotech Inc.
$0.48
Mkt Cap: $0.1B
Explore stocks similar to ZEN.V for comparison